Related Announcements

RFA-DK-21-025 - Pediatric Obesity Discovery Science Research to Improve Understanding of Risk and Causal Mechanisms for Obesity in Early Life (R01 Clinical Trial Optional)

Issued by

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Purpose

This Notice is to inform the applicant community of an increase in funds available and number of anticipated awards for Funding Opportunity Announcement (FOA) RFA-DK-21-025, "Pediatric Obesity Discovery Science Research to Improve Understanding of Risk and Causal Mechanisms for Obesity in Early Life (R01 Clinical Trial Optional)".

Therefore, Section II., the Award Information section of the FOA has been updated to more accurately reflect the funds available and number of anticipated awards as shown below:

Currently Reads:

Section II. Award Information

Funds Available and Anticipated Number of Awards

NIDDK intends to commit $1,400,000 in FY2023 to fund up to 2 awards.

Modified to Read (changes shown in bold italics):

Section II. Award Information

Funds Available and Anticipated Number of Awards

NIDDK expects to commit $2,250,000 in FY2023 to fund up to 3 awards.

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Voula Osganian, M.D., Sc.D., M.P.H.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: (301) 827-6939
Email: voula.osganian@nih.gov